1-phenyl-2-(1-pyrrolidinyl)-1-pentanone and Acute-Disease

1-phenyl-2-(1-pyrrolidinyl)-1-pentanone has been researched along with Acute-Disease* in 2 studies

Other Studies

2 other study(ies) available for 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone and Acute-Disease

ArticleYear
GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case.
    Forensic science international, 2016, Volume: 259

    α-Pyrrolidinovalerophenone (α-PVP) is a synthetic cathinone belonging to the group of "second generation" pyrrolidinophenones that becomes more and more popular as a designer psychostimulant. Here we provide toxicological analytical support for a severe poisoning with α-PVP. Serum and urine samples that were sent to our laboratory were subjected to a general unknown screening procedure. The procedure includes immunoassay-based screening of drugs of abuse in serum and systematic toxicological analysis of urine and serum after neutral and basic liquid-liquid extraction followed by gas chromatography-mass spectrometry (GC-MS). Whereas the immunoassay delivered negative results, analyzing the urine sample by GC-MS in full scan mode disclosed the presence of α-PVP and its metabolites α-(2″-oxo-pyrrolidino)valerophenone (2″-oxo-α-PVP) and 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-ol (OH-α-PVP). In the acetylated urine sample we found additionally N,N-bis-dealkyl-PVP. In serum, α-PVP could be detected after solid phase extraction and a concentration of 29ng/mL was determined. Other forensic relevant substances were not detected. The presented data can explain the psychotic symptoms and behavioural pattern of the subject after abuse of α-PVP, leading to a clinical condition similar to excited delirium syndrome.

    Topics: Acute Disease; Adult; Delirium; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Male; Pyrrolidines

2016
Elimination half-life of alpha-pyrrolidinovalerophenone in an acute non-fatal intoxication.
    Clinical toxicology (Philadelphia, Pa.), 2016, Volume: 54, Issue:6

    Topics: Acute Disease; Administration, Intravenous; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Half-Life; Humans; Male; Midazolam; Psychoses, Substance-Induced; Pyrrolidines; Tachycardia; Young Adult

2016